Cure Pharmaceutical News and Activities
Presence
Headquarters: United States (USA)
Cure Pharmaceutical is a company listed under the stock ticker CURR (US).
Executives
View the org chart displaying its 6 main executives
Most searched biographies at Cure Pharmaceutical
- Robert Davidson, Chief Executive Officer and Chairman of the Board
- Raymond Watt, Director
- Mike Valentino, Chairman of the Board
Popular executive movements at Cure Pharmaceutical
- Patricia Hess, Chief Operating Officer, has left the company (posted on May 21 2026).
Create your alert
to follow the executive moves at Cure Pharmaceutical.
Pharmaceuticals
Cure Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Cure Pharmaceutical
- CURE Pharmaceutical Letter to Shareholders - CURE Pharmaceutical
- CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins - CURE Pharmaceutical
- Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV - CURE Pharmaceutical
- Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins - CURE Pharmaceutical
- CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman - CURE Pharmaceutical
- CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call - CURE Pharmaceutical
- CURE Pharmaceutical Announces the Appointment of New Board Member - CURE Pharmaceutical
- CURE Pharmaceutical Announces Teleconference With Investors - CURE Pharmaceutical
- CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million - CURE Pharmaceutical
- CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children's Hospital Medical Center (CCHMC) Using CURE's Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell Tran
- View more press releases Close
Social media about Cure Pharmaceutical
- Cure Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Cure Pharmaceutical on LinkedIn, X (Twitter) & YouTube
